ARTL Earnings — Artelo Biosciences, Inc. Common Stock Post-ER Performance | BigEarnings
ARTL — Artelo Biosciences, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$1.40
Market Cap$4.9M
P/E—
52W Range$1.19 – $85.80
Next Earnings2026-08-12
About Artelo Biosciences, Inc. Common Stock
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
